Product Information
BUMETANIDE 2 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1767 per EA under NDC 00832054211. Its NADAC has been published 442 times since Mar 7, 2018.
FDA first approved this application on Jan 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832054211
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209916FDA Approved
1/23/2018
TE Code
AB
On Market Since
1/30/2018
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 2 MG TABLET has been published 442 times since Mar 7, 2018, and over the history we have for it it has declined 82.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1767 per EA |
|---|---|
| All-time high | $1.0081 (Apr 11, 2018) |
| All-time low | $0.1717 (Jul 22, 2026) |
| 52-week high | $0.2544 |
| 52-week low | $0.1717 |
| Median price | $0.4063 |
| Average price | $0.4808 |
| Largest weekly change | +35.6% (Jun 19, 2024) |
| Weeks tracked | 442 |
| Tracking since | Mar 7, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUMETANIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUMETANIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1767 per EA (NDC 00832054211), effective Aug 19, 2026.
How has the price of BUMETANIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 82.2%. It has been tracked across 442 weekly CMS publications since Mar 7, 2018.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?
Since Mar 7, 2018, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.1717 (Jul 22, 2026) to a high of $1.0081 (Apr 11, 2018), with a median of $0.4063 per EA.
Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BUMETANIDE 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUMETANIDE 2 MG TABLET?
BUMETANIDE 2 MG TABLET (NDC 00832054211) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.